Pharmaceutical Giants Duke it out over Resveratrol

In 2007, Drug giant Glaxo purchased Sirtris Pharmaceuticals for $720 Million.  Sirtris is now in the test phase of several drugs for the treatment of Cancer and Diabetes, based on the Resveratrol molecule. Sirtris gets its name from the well know ability of Resveratrol to activate the SIRT genes, which produce the Sirtuin enzymes.  Resveratrol [...]